Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Barinthus Biotherapeutics Plc ADR (BRNS)

Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Barinthus Biotherapeutics Plc ADR 20400 CENTURY BOULEVARD SUITE 210 GERMANTOWN MD 20874 USA

www.barinthusbio.com Employees: 105 P: 443-917-0966

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases. The company's product pipeline includes VTP-300, VTP-200, VTP-1000, VTP-850 and VTP-1100. Barinthus Biotherapeutics plc, formerly known as Vaccitech plc, is based in OXFORD, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 28,989
Enterprise Value, $K -83,411
Shares Outstanding, K 40,830
Float, K 36,461
% Float 89.30%
Short Interest, K 7
Short Float 0.02%
Days to Cover 1.00
Short Volume Ratio 0.02
% of Insider Shareholders 10.70%
% of Institutional Shareholders 25.20%

Financials:

Annual Sales, $ 14,970 K
Annual Net Income, $ -61,070 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -14,570 K
EBIT, $ -82,380 K
EBITDA, $ -76,580 K

Growth:

1-Year Return -32.38%
3-Year Return -75.93%
5-Year Return 0.00%
5-Year Revenue Growth 118.54%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.36 on 11/07/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -1.88
EPS Growth vs. Prev Qtr 30.77%
EPS Growth vs. Prev Year -71.43%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BRNS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -70.13%
Return-on-Assets % -56.09%
Profit Margin % -407.95%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.35
Book Value/Share 2.07
Interest Coverage -1,223.60
60-Month Beta -0.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar